NEW YORK--(BUSINESS WIRE)--April 10, 2006--Callisto Pharmaceuticals, Inc. (AMEX:KAL - News; FWB:CA4), a developer of new drug treatments in the fight against cancer and other major health threats, announced today that an abstract on a WP 1066, a Degrasyn drug candidate, was the subject of a poster presentation at the 97th annual meeting of the American Association of Cancer Research (AACR) in Washington D.C., April 1-5, 2006, a leading scientific conference in the field of cancer research.
